Linda Johnson

Scholarships for union members will mark historic DC march

newsmediaguild.org — To commemorate the upcoming 50th anniversary of the historic March on Washington, the AFL-CIO and the Union Privilege program have announced new scholarships being offered to union members. The one-time, ,000 scholarships are for study for the academic year from fall 2013 through summer 2014.

Scholarships for union members will mark historic DC march

newsmediaguild.org — To commemorate the upcoming 50th anniversary of the historic March on Washington, the AFL-CIO and the Union Privilege program have announced new scholarships being offered to union members. The one-time, ,000 scholarships are for study for the academic year from fall 2013 through summer 2014.

Poor to get cervical cancer vaccine for $4.50 a dose

news.msn.com — Two drugmakers will make HPV vaccines Gardasil and Cervarix available to poor girls worldwide for a fraction of its former cost. TRENTON, N.J. - Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer.

IMS: US medicine spending shows rare dip in 2012 - WNCT | 9 On Your Side Greenville NC & Eastern NC News

wnct.com — By LINDA A. JOHNSONAP Business Writer TRENTON, N.J. (AP) - Spending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back on use of health care services.

Bashful? Buy the little blue pill online - WKRG News 5

wkrg.com — By LINDA A. JOHNSONAP Business Writer TRENTON, N.J. (AP) - Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill. In a first for the drug industry, Pfizer Inc.

Generic competition cuts Merck's Q1 sales, profit

news.yahoo.com — WHITEHOUSE STATION, N.J. (AP) - Drugmaker Merck & Co. is reporting lower first-quarter results and cutting its 2013 profit forecast by 15 cents a share. It also is announcing a huge share buyback, up to $15 billion worth of its stock.

Earnings Preview: J&J 1Q to focus on newest drugs

businessweek.com — TRENTON, N.J. (AP) - Johnson & Johnson will highlight the recent approval of its first drug in the huge diabetes market, plus progress toward getting two other drugs approved, when it reports first-quarter results before the stock market opens Tuesday. WHAT TO WATCH FOR: The world's biggest maker of health care products will focus on the March 29 U.S.

Johnson & Johnson shares dip on analyst downgrade

nz.finance.yahoo.com — Read 'Johnson & Johnson shares dip on analyst downgrade' on Yahoo! Finance New Zealand. Shares of Johnson & Johnson fell Monday after a J.P. Morgan analyst downgraded the health care giant's stock, saying it now trades at an 8 percent premium to the value of its parts and he expects the company ...

Drugmaker Bristol-Myers replaces research director in latest pharmaceutical industry shuffling

therepublic.com — Bristol-Myers Squibb Co. will replace its top researcher with a physician and former medical school professor who has worked in pharmaceutical industry research for more than two decades. Dr. Francis Cuss, 58, will become the New York-based drugmaker's executive vice president and chief scientific officer on July 1.

Drugmaker Sanofi building new factory in Vietnam

businessweek.com — French drugmaker Sanofi SA said Friday that it's building a new medicine factory in Vietnam to supply drugs to that country and others in the region. The move is part of a fast-growing trend among major international pharmaceutical companies to put factories and research centers in emerging markets that the industry increasingly is targeting for growth.